rs7355045

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005529.7(HSPG2):​c.8464+143A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.804 in 979,460 control chromosomes in the GnomAD database, including 317,727 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.78 ( 46024 hom., cov: 32)
Exomes 𝑓: 0.81 ( 271703 hom. )

Consequence

HSPG2
NM_005529.7 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.41

Publications

5 publications found
Variant links:
Genes affected
HSPG2 (HGNC:5273): (heparan sulfate proteoglycan 2) This gene encodes the perlecan protein, which consists of a core protein to which three long chains of glycosaminoglycans (heparan sulfate or chondroitin sulfate) are attached. The perlecan protein is a large multidomain proteoglycan that binds to and cross-links many extracellular matrix components and cell-surface molecules. It has been shown that this protein interacts with laminin, prolargin, collagen type IV, FGFBP1, FBLN2, FGF7 and transthyretin, etc., and it plays essential roles in multiple biological activities. Perlecan is a key component of the vascular extracellular matrix, where it helps to maintain the endothelial barrier function. It is a potent inhibitor of smooth muscle cell proliferation and is thus thought to help maintain vascular homeostasis. It can also promote growth factor (e.g., FGF2) activity and thus stimulate endothelial growth and re-generation. It is a major component of basement membranes, where it is involved in the stabilization of other molecules as well as being involved with glomerular permeability to macromolecules and cell adhesion. Mutations in this gene cause Schwartz-Jampel syndrome type 1, Silverman-Handmaker type of dyssegmental dysplasia, and tardive dyskinesia. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2014]
HSPG2 Gene-Disease associations (from GenCC):
  • Schwartz-Jampel syndrome type 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • Silverman-Handmaker type dyssegmental dysplasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen, Labcorp Genetics (formerly Invitae)
  • Schwartz-Jampel syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 1-21845965-T-C is Benign according to our data. Variant chr1-21845965-T-C is described in ClinVar as [Benign]. Clinvar id is 1245045.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.809 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HSPG2NM_005529.7 linkc.8464+143A>G intron_variant Intron 64 of 96 ENST00000374695.8 NP_005520.4 P98160

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HSPG2ENST00000374695.8 linkc.8464+143A>G intron_variant Intron 64 of 96 1 NM_005529.7 ENSP00000363827.3 P98160
HSPG2ENST00000453796.1 linkn.*231A>G downstream_gene_variant 2

Frequencies

GnomAD3 genomes
AF:
0.775
AC:
117918
AN:
152070
Hom.:
45976
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.700
Gnomad AMI
AF:
0.807
Gnomad AMR
AF:
0.709
Gnomad ASJ
AF:
0.894
Gnomad EAS
AF:
0.821
Gnomad SAS
AF:
0.821
Gnomad FIN
AF:
0.824
Gnomad MID
AF:
0.829
Gnomad NFE
AF:
0.815
Gnomad OTH
AF:
0.789
GnomAD4 exome
AF:
0.809
AC:
669565
AN:
827274
Hom.:
271703
AF XY:
0.812
AC XY:
347087
AN XY:
427708
show subpopulations
African (AFR)
AF:
0.707
AC:
15026
AN:
21242
American (AMR)
AF:
0.694
AC:
26576
AN:
38280
Ashkenazi Jewish (ASJ)
AF:
0.891
AC:
17111
AN:
19206
East Asian (EAS)
AF:
0.839
AC:
29181
AN:
34788
South Asian (SAS)
AF:
0.812
AC:
51411
AN:
63282
European-Finnish (FIN)
AF:
0.816
AC:
29331
AN:
35928
Middle Eastern (MID)
AF:
0.848
AC:
2430
AN:
2864
European-Non Finnish (NFE)
AF:
0.815
AC:
466753
AN:
572356
Other (OTH)
AF:
0.807
AC:
31746
AN:
39328
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
7122
14244
21366
28488
35610
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7616
15232
22848
30464
38080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.776
AC:
118021
AN:
152186
Hom.:
46024
Cov.:
32
AF XY:
0.774
AC XY:
57595
AN XY:
74400
show subpopulations
African (AFR)
AF:
0.701
AC:
29077
AN:
41488
American (AMR)
AF:
0.709
AC:
10852
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.894
AC:
3105
AN:
3472
East Asian (EAS)
AF:
0.821
AC:
4247
AN:
5170
South Asian (SAS)
AF:
0.821
AC:
3962
AN:
4828
European-Finnish (FIN)
AF:
0.824
AC:
8741
AN:
10614
Middle Eastern (MID)
AF:
0.830
AC:
244
AN:
294
European-Non Finnish (NFE)
AF:
0.815
AC:
55390
AN:
68000
Other (OTH)
AF:
0.789
AC:
1669
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1379
2758
4138
5517
6896
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
864
1728
2592
3456
4320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.796
Hom.:
6001
Bravo
AF:
0.766
Asia WGS
AF:
0.828
AC:
2877
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aug 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
5.7
DANN
Benign
0.24
PhyloP100
-1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7355045; hg19: chr1-22172458; COSMIC: COSV65970143; COSMIC: COSV65970143; API